DPHARM Idol Disrupt is an exciting live competition where innovative companies showcase their disruptive technologies to a panel of 12 judges - including R&D executives, patient advocates, and life science investors. Our CEO, Chris Venezia, had just six minutes to demonstrate how ProofPilot’s end-to-end Clinical Experience Platform supports sites, patients, and sponsors throughout the entire clinical trial journey, from recruitment to the return of results, ensuring a more burden-free and efficient approach.
What Drives Decision Making?
To set the stage, Chris acknowledged a fundamental truth: people make interesting choices. Whether it’s quirky summer trends or adding ice to wine (controversial, but delicious!), decisions are driven by various psychological factors. In clinical trials, these decisions boil down to three key personality types that we often encounter:
To stand out as the obvious choice, sponsors need to alleviate these concerns and simplify decision-making. That’s where ProofPilot steps in.
How ProofPilot Makes You the Sponsor of Choice
What is Sponsor of Choice? Simply put, it means a site will choose to work with you over another sponsor. ProofPilot’s platform is designed to reduce the complexity and stress that sites face when evaluating and conducting clinical trials. We achieve this by offering a seamless, white-labeled solution through our Study CoPilot platform, which includes three core pillars:
With ProofPilot’s platform, sponsors can address the concerns of all three decision-making personas. Whether it’s Susie’s resistance to change, Charlie’s analysis paralysis, or Larry’s fear of failure. Our solution makes it easy for sites to say yes to your study.
Honored to Share the Stage
As we reflect on the DPHARM Idol Disrupt competition, it’s evident that many companies are dedicated to driving innovation in clinical trials. We had strong competition from the other DPHARM Idol Disrupt finalist contenders, which included:
Beyond Theories
At ProofPilot, we’re focused on delivering a smooth journey for sites, patients, and sponsors. And this isn’t just a theory - our platform has seen real success, gaining recognition across the industry and helping sponsors execute trials more efficiently, with fewer headaches for sites and patients alike. We truly know what we’re talking about; in fact, 30% of the judging panel at IDOL consisted of customers or board members. This reflects our commitment to understanding the pain points faced by our industry.
Curious to learn how our Clinical Experience Platform works? Book a demo to see it in action!